|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0460 AUD | -.--% |
|
-4.17% | -88.92% |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
| Market Cap | 67.79M 47.59M 41.37M 38.5M 35.35M 66.76M 4.54B 454M 178M 2.26B 179M 175M 7.58B | P/E 2026 * |
-1.19x | P/E 2027 * | -1.69x |
|---|---|---|---|---|---|
| Enterprise Value | 2.79M 1.96M 1.7M 1.59M 1.46M 2.75M 187M 18.7M 7.34M 93.18M 7.36M 7.2M 312M | EV / Sales 2026 * |
0.16x | EV / Sales 2027 * | -2.97x |
| Free-Float |
96.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -4.17% | ||
| 1 month | -13.21% | ||
| 3 months | -22.03% | ||
| 6 months | -88.35% | ||
| Current year | -88.92% |
| 1 week | 0.05 |  | 0.05 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.03 | | 0.47 |
| 1 year | 0.03 | | 0.47 |
| 3 years | 0.03 | | 0.48 |
| 5 years | 0.03 | | 0.71 |
| 10 years | 0.03 | | 0.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 53 | 09/07/2014 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/2018 |
Stephan Winckels
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Voigt
BRD | Director/Board Member | 53 | 09/07/2014 |
Russell Howard
CHM | Chairman | 76 | 17/11/2017 |
Pete Meyers
BRD | Director/Board Member | 57 | 12/02/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/5/25 A | Free | Director | 707,232 | 0.0480% | ||
| 12/5/25 A | Free | Director | 2,058,631 | 0.1399% | ||
| 12/5/25 A | Free | Chairman | 1,573,646 | 0.1069% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -4.17% | -82.96% | -84.92% | 47.59M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +403.17% | +614.40% | 39.87B | |
| -1.16% | +12.96% | +26.45% | +5.03% | 38.68B | |
| -1.88% | -3.03% | +4.94% | +47.52% | 35.13B | |
| -1.74% | +5.12% | +9.58% | +46.02% | 29.79B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.21% | -4.04% | +35.09% | +127.95% | 16.11B | |
| -0.64% | +2.65% | +1.25% | +8.92% | 13.61B | |
| -1.19% | -1.32% | -3.32% | -34.94% | 12.62B | |
| Average | -1.35% | +0.53% | +43.61% | +82.36% | 25.05B | |
| Weighted average by Cap. | -1.60% | +2.03% | +76.83% | +128.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.23M 12.1M 10.52M 9.79M 8.99M 16.97M 1.15B 115M 45.28M 575M 45.43M 44.43M 1.93B | 3.16M 2.22M 1.93M 1.79M 1.65M 3.11M 212M 21.13M 8.29M 105M 8.32M 8.14M 353M |
| Net income | -58.54M -41.09M -35.72M -33.25M -30.53M -57.64M -3.92B -392M -154M -1.95B -154M -151M -6.55B | -47.05M -33.03M -28.71M -26.72M -24.53M -46.33M -3.15B -315M -124M -1.57B -124M -121M -5.26B |
| Net Debt | -65M -45.63M -39.66M -36.92M -33.89M -64.01M -4.36B -435M -171M -2.17B -171M -168M -7.27B | -77.18M -54.18M -47.09M -43.84M -40.25M -76M -5.17B -517M -203M -2.57B -203M -199M -8.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | A$0.0460 | -.--% | 2,758,273 |
| 30/07/26 | A$0.0460 | -2.13% | 7,305,934 |
| 29/07/26 | A$0.0470 | -.--% | 2,167,778 |
| 28/07/26 | A$0.0470 | -2.08% | 25,866,235 |
| 27/07/26 | A$0.0480 | -.--% | 4,965,061 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMM Stock
Select your edition
All financial news and data tailored to specific country editions
